Utah Medical Products
UTMD
75 hedge funds and large institutions have $180M invested in Utah Medical Products in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 7 closing their positions.
65.9% more ownership
Funds ownership: 0% → 65.9% (+66%)
60% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 20
21% more capital invested
Capital invested by funds: $149M → $180M (+$31.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 79 → 75 (-4)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.2M |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$918K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$914K |
| 4 |
Morgan Stanley
New York
|
+$694K |
| 5 |
JP Morgan Chase
New York
|
+$494K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$6.5M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$817K |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$361K |
| 4 |
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
|
-$331K |
| 5 |
SIM
Spark Investment Management
New York
|
-$233K |
UTMD Hedge Fund Activity: Q4 2016 in Review
75 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2016, worth a combined $180M — up 21% from $149M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of UTMD and 6 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 32 added.
The largest buyer was Wells Fargo, adding an estimated $1.2M. The largest seller was Nine Ten Capital Management, cutting an estimated $6.5M.
- 75 institutional investors held Utah Medical Products (UTMD) as of Q4 2016, down from 79 in Q3 2016.
- Funds reported $180M of Utah Medical Products stock for Q4 2016, up 21% quarter-over-quarter.
- 6 funds opened new Utah Medical Products positions in Q4 2016 and 7 closed out, a net change of -1 holder.
- The largest Utah Medical Products buyer in Q4 2016 was Wells Fargo, an estimated $1.2M added.
- The largest Utah Medical Products seller in Q4 2016 was Nine Ten Capital Management, an estimated $6.5M sold.
Based on aggregated 13F filings for Q4 2016.